EMA advises clinical trial managers over impact of war in Ukraine

Clinical trials in the Ukraine could be impacted by Russia’s invasion of the country, which is why the EMA is now offering advice on how to proceed based on lessons learned during Covid-19.
Employees at a Ukrainian hospital in Trostyanets say Russian forces have attacked the hospital during its siege of the city | Photo: Thomas Peter/REUTERS / X90176
Employees at a Ukrainian hospital in Trostyanets say Russian forces have attacked the hospital during its siege of the city | Photo: Thomas Peter/REUTERS / X90176
by ulrich quistgaard, translated by daniel pedersen

Russia’s invasion of Ukraine has been the cause of many disruptions in the region at large, and there is now also a great chance of clinical trials being impacted, according to the European Medicines Agency (EMA).

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading